Cargando…

Development and validation of a polygenic hazard score for aggressive prostate cancer identification

Detalles Bibliográficos
Autores principales:	Mohamed, Nihal E., Tewari, Ashutosh K., Yadav, Kamlesh K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797799/ https://www.ncbi.nlm.nih.gov/pubmed/35117080 http://dx.doi.org/10.21037/tcr.2018.11.34

Ejemplares similares

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts
por: Seibert, Tyler M, et al.
Publicado: (2018)

Polygenic hazard score is associated with prostate cancer in multi-ethnic populations
por: Huynh-Le, Minh-Phuong, et al.
Publicado: (2021)

Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score
por: Desikan, Rahul S., et al.
Publicado: (2017)

Polygenic risk score for tumor aggressiveness and early-onset prostate cancer in Asians
por: Song, Sang Hun, et al.
Publicado: (2023)

Validation of a prostate cancer polygenic risk score
por: Black, Mary H., et al.
Publicado: (2020)

Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score
por: Huynh-Le, Minh-Phuong, et al.
Publicado: (2022)

Headaches and polygenic scores
por: Vilhjálmsson, Bjarni J., et al.
Publicado: (2019)

Polygenic risk and hazard scores for Alzheimer's disease prediction
por: Leonenko, Ganna, et al.
Publicado: (2019)

Development and testing of a polygenic risk score for breast cancer aggressiveness
por: Shieh, Yiwey, et al.
Publicado: (2023)

The effect of sample size on polygenic hazard models for prostate cancer
por: Karunamuni, Roshan A., et al.
Publicado: (2020)

Correction: Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score
Publicado: (2017)

Polygenic risk scores and rheumatic diseases
por: Brown, Matthew A., et al.
Publicado: (2021)

Development and validation of a polygenic hazard score to predict prognosis and adjuvant chemotherapy benefit in early-stage non-small cell lung cancer
por: Li, Dan-Hua, et al.
Publicado: (2022)

Assessment of a polygenic hazard score for the onset of pre-clinical Alzheimer’s disease
por: Vacher, Michael, et al.
Publicado: (2022)

Alzheimer's polygenic hazard score in SuperAgers: SuperGenes or SuperResilience?
por: Spencer, Barbara E., et al.
Publicado: (2022)

Polygenic score: An anchor holding the whole life course
por: Jin, Guangfu, et al.
Publicado: (2023)

Generalisation of genomic findings and applications of polygenic risk scores
por: Corpas, Manuel, et al.
Publicado: (2023)

Prostate cancer polygenic risk score and prediction of lethal prostate cancer
por: Klein, Robert J., et al.
Publicado: (2022)

Association between Incidental Pelvic Inflammation and Aggressive Prostate Cancer
por: Chakravarty, Dimple, et al.
Publicado: (2022)

Gene set enrichment analysis to create polygenic scores: a developmental examination of aggression
por: Elam, Kit K., et al.
Publicado: (2019)

Polygenic Hazard Score Associated Multimodal Brain Networks Along the Alzheimer’s Disease Continuum
por: Li, Kaicheng, et al.
Publicado: (2021)

Polygenic risk scores and their potential clinical use in psychiatry: are we there yet?
por: Fries, Gabriel R.
Publicado: (2020)

An analysis of polygenic risk scores for non-alcoholic fatty liver disease
por: Jun, Dae Won
Publicado: (2021)

Are we nearly there yet? Starts and stops on the road to use of polygenic scores
por: Moorthie, Sowmiya, et al.
Publicado: (2023)

Polygenic risk scores and early manifestations of attention‐deficit/hyperactivity disorder
por: Larsson, Henrik, et al.
Publicado: (2022)

Understanding polygenic models, their development and the potential application of polygenic scores in healthcare
por: Babb de Villiers, Chantal, et al.
Publicado: (2020)

Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer Risk
por: Hughes, Elisha, et al.
Publicado: (2020)

Circadian Rhythm Disruption as a Contributor to Racial Disparities in Prostate Cancer
por: Dasari, Sonali S., et al.
Publicado: (2022)

Interpreting polygenic scores, polygenic adaptation, and human phenotypic differences
por: Rosenberg, Noah A, et al.
Publicado: (2018)

Prostate cancer risk prediction using a polygenic risk score
por: Sipeky, Csilla, et al.
Publicado: (2020)

Evaluation of Polygenic Risk Scores for Prediction of Prostate Cancer in Korean Men
por: Oh, Jong Jin, et al.
Publicado: (2020)

Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer
por: Plym, Anna, et al.
Publicado: (2021)

Enriching the design of Alzheimer's disease clinical trials: Application of the polygenic hazard score and composite outcome measures
por: Banks, Sarah J., et al.
Publicado: (2020)

Polygenic hazard score modified the relationship between hippocampal subfield atrophy and episodic memory in older adults
por: Xu, Jingjing, et al.
Publicado: (2022)

Derivation and Validation of Genome‐Wide Polygenic Score for Ischemic Heart Failure
por: Paranjpe, Ishan, et al.
Publicado: (2021)

Importance of hazard identification in risk management
por: GAN, Siok Lin
Publicado: (2019)

Induction of Neuroendocrine Differentiation in Prostate Cancer Cells by Dovitinib (TKI-258) and its Therapeutic Implications
por: Yadav, Shalini S., et al.
Publicado: (2017)

Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry Composition
por: Hughes, Elisha, et al.
Publicado: (2022)

Sibling validation of polygenic risk scores and complex trait prediction
por: Lello, Louis, et al.
Publicado: (2020)

Long Life Family Study Shows Reduced Coronary Artery Disease Despite High Polygenic Hazard Scores
por: Feitosa, Mary, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_80235k38pg5go9n4hd73ob6c0k